|
|
Article: Medtronic Applauds Expanded ACC/AHA/NASPE Guidelines as Life-Saving and Life-Changing Opportunities for Hundreds of Thousands of Heart Failure and Heart Attack Patients.
- Article from:
- Business Wire
- Article date:
- September 25, 2002
CopyrightCOPYRIGHT 2002 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors & Health/Medical Writers
MINNEAPOLIS--(BUSINESS WIRE)--Sept. 25, 2002
New Guidelines Include Categories for Cardiac Resynchronization
Therapy and MADIT II Indication
Medtronic (NYSE:MDT) today announced its support for the expanded guidelines issued by the American College of Cardiology (ACC), American Heart Association (AHA) and North American Society of Pacing and Electrophysiology (NASPE) as life-changing and life-saving opportunities for the hundreds of thousands of patients who suffer from heart failure and/or are at risk of sudden cardiac arrest following heart attacks.
The ACC/AHA/NASPE guidelines, ...